Luminal A Breast Cancer: How Feasible is Omitting Axillary Dissection Without Neoadjuvant Therapy

BACKGROUND: Luminal A breast cancer has a good prognosis and the criteria for adjuvant and neoadjuvant chemotherapy (NAC) are not clear. The aim of this study was to present our results of upfront surgery and long-term survival in luminal A tumors as well as the rates of protection from axillary dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Yüksel, Cemil, Aksel, Bülent, Doğan, Lütfi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356774/
https://www.ncbi.nlm.nih.gov/pubmed/35974878
http://dx.doi.org/10.1155/2022/8284814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356774/
https://www.ncbi.nlm.nih.gov/pubmed/35974878
http://dx.doi.org/10.1155/2022/8284814

Ejemplares similares